1Buchthal SD, den Hollander JA, Merz CN ,et al. Abnormal myocardial phosphorus - 31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms[ J]. N Engl J Med. 2000,342(12) :829 ~ 835.
2Reis SE, Holubkov R, Lee JS,et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Womens Ischemia Syndrome Evaluation ( WISE ) study[J]. J Am Coil Cardiol. 1999,33(6) :1469 ~ 1475.
3Johnson BD, Shaw LJ, Buchthal SD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease:results from the national institutes of health - national heart, lung,and blood institute - sponsored womens ischemia syndrome evaluation (WISE) [J]. Circulation. 2004,109(24):2993~2999.
4Reis SE, Holubkov R, Conrad Smith A J, et al. Coronary microvaseular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study [J]. Am Heart J. 2001,141 (5) :735 ~ 741.
5Kaski JC, Aldama G, Cosin - Sales J. Cardiac syndrome X : diagnosis, pathogenesis and management [ J ]. Am J Cardiovasc Drugs.2004,4(3) :179 ~ 194.
7Bfitten MB, Zeiher AM, Schachinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long - term outcome [ J ]. Coron Artery Dis. 2004,15(5) :259 ~ 264.
8Marroquin OC, Holubkov R, Edmundowicz D, et al. Heterogeneity of micmvascular dysfuntion in women with chest pain not attributable to coronary artery disease: Implications for clinical practice [ J ]. Am Heart J. 2003,145 (4) : 628 ~ 635.
10Farkas K, Kolossvary E, Jarai Z, et al. Non -invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension [ J ]. Atherosclerosis. 2004, 173(1):97~102.
1Yokoyama I, Ohtake T, Momomura S, et al. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation, 1996, 94:3232--3238.
2Kyriakidis M K, Dernellis J M, Androulakis A E, et al. Changes in phasic coronary blood flow velocity profile and relative coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy. Circulation,1997, 96:834--841.
3Antony I, Nitenberg A. Coronary flow reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries. Am J Hypertens, 1997, 10:181--188.
4White C W, Kern M J. Clinical applications of Doppler coronary flow reserve measurement. Am J Cardiol,1993, 71: 10D--16D.
5Suzuki H, Takeyama Y, Koba S, et al. Small vessel pathology and coronary hemodynamics in patients with microvascular angina. Int J Cardiol, 1994, 43:139--150.
6Garot P, Teiger E, Dupouy P, et al. Coronary microcirculation and cardiovascular pathology. Drugs, 1999,58:23--31.
7Gavin J B, Maxwell L, Edgar S G. Microvascular involvement in cardiac pathology. J Mol Cell Cardiol,1998, 30: 2531--2540.
8Ofili E O, Labovitz A J, Kern M J. Coronary flow velocity dynamics in normal and diseased arteries. Am J Cardiol, 1993, 71: 3D-9D.